Streetbeat News

Analyst Ratings

RVLV

Morgan Stanley analyst Lauren Schenk has reiterated an Equal-Weight rating on Revolve Group (NYSE:RVLV) and maintained a $19 price target.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 7:08 pm

REZI

Morgan Stanley analyst Erik Woodring has maintained an Equal-Weight rating on Resideo Technologies (NYSE:REZI) and lowered the price target from $21 to $16.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 7:06 pm

RGA

Morgan Stanley analyst Nigel Dally has reiterated an Equal-Weight rating on Reinsurance Gr (NYSE:RGA) and maintained a $160 price target.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 7:04 pm

REGN

Morgan Stanley analyst Matthew Harrison maintains an Overweight rating on Regeneron Pharmaceuticals (NASDAQ:REGN) and raises the price target from $897 to $912.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 7:01 pm

GMED

In the last quarter, Globus Medical (NYSE:GMED) received indifferent ratings from three analysts. The company's average 12-month price target is $63.67, an increase of 1.06% from the previous average price target of $63.00.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 7:00 pm

EPAM

Over the last quarter, 22 analysts have given ratings for EPAM Sys (NYSE:EPAM), with an average price target of $252.77, indicating a potential upside from the current price of $247.52. The current average has decreased by 18.0% from the previous average price target of $308.26.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 7:00 pm

APD

Analysts have provided ratings for Air Products & Chemicals (NYSE:APD) within the last quarter, with 4 bullish, 1 somewhat bullish, and 1 indifferent. The average price target is $332.33, implying an upside from the current price of $284.975. This represents a 0.92% decrease from the previous average price target of $335.40.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 7:00 pm

TRIP

In the last quarter, TripAdvisor (NASDAQ:TRIP) received 2 bullish, 4 indifferent, and 2 somewhat bearish ratings from analysts. The average 12-month price target for the company is $19.38, a decrease of 3.77% from the previous average of $20.14.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 7:00 pm

VC

In the last quarter, Visteon (NASDAQ:VC) received mixed analyst ratings with 1 bullish, 2 somewhat bullish, 2 indifferent, and 2 somewhat bearish. The company has an average 12-month price target of $157.57, which has increased by 4.21% over the past month.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 7:00 pm

ALKT

Alkami Technology (NASDAQ:ALKT) has received a mix of bullish and indifferent ratings from 8 analysts over the last quarter. The average price target for the stock is $19.38, which is 15.7% higher than the previous average of $16.75 and suggests an upside from the current price of $16.39.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 7:00 pm